Advanced Cell Diagnostics, Inc., doing business as ACD, has been awarded a firm fixed price purchase order valued at $10,574.80 by the National Institutes of Health's National Institute of Mental Health to provide reagents including the RNAScope Hiplex Probe, RNAScope Intro Pack for Hiplex 12 reagents kit. Performance will take place in Newark, California from July 5, 2023 through September 30, 2023. The award is for reagents to support the NIH's biomedical research efforts. No set aside designation or subcontractors are indicated. Bio-Techne Corporation, doing business as Bio-Techne, is identified as ACD's parent company.
Generated 12/20/23, 1:09 PM